Want to track 1801 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innovent Biologics Inc. (1801) Statistics
Valuation metrics
Market Cap 60.58B
Enterprise value 119.12B
Trailing P/E (ttm) 154.19
Forward P/E -
PEG ratio 0.18
Price/Sales (ttm) 10.25
Price/Book (mrq) 6.79
Enterprise Value/Revenue 9.13
Enterprise Value/EBITDA 90.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 19.04M
Average volume (90 days) 14.11M
Price summary
52-Week low 69.55
52-Week high 109.1
Beta -
50-Day moving average 81.21
200-Day moving average 84.02
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.06%
Operating margin 0.06%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 7.62
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 10.65
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 2.62%
Book value per share (mrq) 11.78
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
